[HTML][HTML] Pharmacotherapy of anxiety disorders: current and emerging treatment options

A Garakani, JW Murrough, RC Freire, RP Thom… - Frontiers in …, 2020 - frontiersin.org
Anxiety disorders are the most prevalent psychiatric disorders and a leading cause of
disability. While there continues to be expansive research in posttraumatic stress disorder …

Benzodiazepines remain important therapeutic options in psychiatric practice

SL Dubovsky, D Marshall - Psychotherapy and Psychosomatics, 2022 - karger.com
Benzodiazepines and medications acting on benzodiazepine receptors that do not have a
benzodiazepine structure (z-drugs) have been viewed by some experts and regulatory …

Sex differences in anxiety and depression clinical perspectives

M Altemus, N Sarvaiya, CN Epperson - Frontiers in neuroendocrinology, 2014 - Elsevier
Sex differences are prominent in mood and anxiety disorders and may provide a window
into mechanisms of onset and maintenance of affective disturbances in both men and …

Benzodiazepine use in the United States

M Olfson, M King, M Schoenbaum - JAMA psychiatry, 2015 - jamanetwork.com
Importance Although concern exists regarding the rate of benzodiazepine use, especially
long-term use by older adults, little information is available concerning patterns of …

[HTML][HTML] Benzodiazepines I: upping the care on downers: the evidence of risks, benefits and alternatives

J Guina, B Merrill - Journal of clinical medicine, 2018 - mdpi.com
Benzodiazepines are some of the most commonly prescribed medications in the world.
These sedative-hypnotics can provide rapid relief for symptoms like anxiety and insomnia …

Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications

F Cosci, G Chouinard - Psychotherapy and psychosomatics, 2020 - karger.com
Studies on psychotropic medications decrease, discontinuation, or switch have uncovered
withdrawal syndromes. The present overview aimed at analyzing the literature to illustrate …

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of panic disorder, social anxiety disorder and generalised …

G Andrews, C Bell, P Boyce, C Gale… - Australian & New …, 2018 - journals.sagepub.com
Objective: To provide practical clinical guidance for the treatment of adults with panic
disorder, social anxiety disorder and generalised anxiety disorder in Australia and New …

Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review

GA Fava, A Gatti, C Belaise, J Guidi… - Psychotherapy and …, 2015 - karger.com
Background: Selective serotonin reuptake inhibitors (SSRI) are widely used in medical
practice. They have been associated with a broad range of symptoms, whose clinical …

The knowns and unknowns of SSRI treatment in young people with depression and anxiety: efficacy, predictors, and mechanisms of action

SE Murphy, LP Capitão, SLC Giles, PJ Cowen… - The Lancet …, 2021 - thelancet.com
The use of SSRIs for the treatment of depression and anxiety in young people is increasing.
However, the effects of SSRIs in adolescence, a time when there are substantial changes in …

Comparison of various sample preparation methods for benzodiazepines in terms of the principles of white analytical chemistry

B Jain, R Jain, PM Nowak, N Ali, MN Ansari… - TrAC Trends in …, 2024 - Elsevier
Benzodiazepines are a highly prevalent class of drugs utilized worldwide. They have been
used as antidepressants and tranquilizers while also possessing the capability to induce …